Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
Holding OLMA?
Track your performance easily

Olema Pharmaceuticals (OLMA) Ownership - Who Owns Olema Pharmaceuticals?

649 Followers

Olema Pharmaceuticals (OLMA) Ownership Overview

31.28%11.01%0.23%10.91%46.57%
31.28% Insiders
0.23% Other Institutional Investors
10.91% ETFs
46.57% Public Companies and
Individual Investors
The ownership structure of Olema Pharmaceuticals (OLMA) stock is a mix of institutional, retail, and individual investors. Approximately 22.15% of the company’s stock is owned by Institutional Investors, 31.28% is owned by Insiders, and 46.57% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 05, 2024
xxxxxxxxxxxxx
$35784000
Jun 06, 2024
xxxxxxxxxxxxx
$17448750
Dec 18, 2023
xxxxxxxxxxxxx
$6870444
Dec 08, 2023
xxxxxxxxxxxxx
$1160000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$339802
Jun 30, 2024
xxxxxxxxxxxxx
$9224634

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,897,173Insider15.54%110,324,945
5,503,600Insider9.61%68,244,640
2,405,628Institution4.20%29,829,787
2,276,378Institution3.98%28,227,087
2,032,400Institution3.55%25,201,760
1,083,958Institution1.89%13,441,079
910,095Institution1.59%11,285,178
873,311Insider1.52%10,829,056
852,554Institution1.49%10,571,670
741,776Insider1.30%9,198,022

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,276,378Institution3.98%28,227,087
910,095Institution1.59%11,285,178
540,742Institution0.94%6,705,201
450,895Institution0.79%5,591,098
321,906Institution0.56%3,991,634
294,250Institution0.51%3,648,700
277,362Institution0.48%3,439,289
228,560Institution0.40%2,834,144
195,762Institution0.34%2,427,449
184,857Institution0.32%2,292,227

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,487,539Institution2.60%17,761,216
1,077,147Institution1.88%13,356,623
1,020,234Institution1.78%12,650,902
589,874Institution1.03%7,043,096
346,234Institution0.60%4,293,302
283,156Institution0.49%3,511,134
180,118Institution0.31%2,233,463
183,072Institution0.32%2,185,880
138,591Institution0.24%1,718,528
121,759Institution0.21%1,509,812

FAQ

Who Owns Olema Pharmaceuticals (OLMA)?
According to the latest TipRanks data, approximately 0.23% of the company's stock is held by institutional investors, 31.28% is held by insiders, and 46.57% is held by retail investors.
    What percentage of Olema Pharmaceuticals (OLMA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.23% of Olema Pharmaceuticals (OLMA) stock is held by institutional investors.
      What percentage of Olema Pharmaceuticals (OLMA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 46.57% of Olema Pharmaceuticals (OLMA) stock is held by retail investors.
        Who owns the most shares of Olema Pharmaceuticals (OLMA)?
        Bvf Partners LP Il owns the most shares of Olema Pharmaceuticals (OLMA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis